Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
4D Molecular Therapeutics Inc (NASDAQ: FDMT) closed the day trading at $18.20 down -31.96% from the previous closing price of $26.75. In other words, the price has decreased by -$31.96 from its previous closing price. On the day, 6.35 million shares were traded. FDMT stock price reached its highest trading level at $28.9269 during the session, while it also had its lowest trading level at $16.7.
Ratios:
For a better understanding of FDMT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.65 and its Current Ratio is at 32.65. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on April 15, 2024, initiated with a Overweight rating and assigned the stock a target price of $459.
On April 15, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 11 ’24 when Bizily Scott sold 1,996 shares for $25.00 per share. The transaction valued at 49,900 led to the insider holds 6,781 shares of the business.
Kirn David sold 12,923 shares of FDMT for $290,598 on Jul 10 ’24. The Chief Executive Officer now owns 1,059,153 shares after completing the transaction at $22.49 per share. On Jul 01 ’24, another insider, Bizily Scott, who serves as the Chief Legal Officer of the company, sold 4,248 shares for $21.36 each. As a result, the insider received 90,758 and left with 1,737 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FDMT now has a Market Capitalization of 1383067264 and an Enterprise Value of 429262112. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.79 while its Price-to-Book (P/B) ratio in mrq is 1.55. Its current Enterprise Value per Revenue stands at 20.988 whereas that against EBITDA is -3.683.
Stock Price History:
The Beta on a monthly basis for FDMT is 2.87, which has changed by 0.00942874 over the last 52 weeks, in comparison to a change of 0.23228896 over the same period for the S&P500. Over the past 52 weeks, FDMT has reached a high of $36.25, while it has fallen to a 52-week low of $9.44. The 50-Day Moving Average of the stock is -24.73%, while the 200-Day Moving Average is calculated to be -14.33%.
Shares Statistics:
Over the past 3-months, FDMT traded about 562.19K shares per day on average, while over the past 10 days, FDMT traded about 1163790 shares per day. A total of 51.70M shares are outstanding, with a floating share count of 43.54M. Insiders hold about 15.79% of the company’s shares, while institutions hold 97.21% stake in the company. Shares short for FDMT as of 1719532800 were 9891860 with a Short Ratio of 17.60, compared to 1717113600 on 9575719. Therefore, it implies a Short% of Shares Outstanding of 9891860 and a Short% of Float of 19.82.
